Home > Insider Trading > Filing (0001649094-24-000080)

Filing Details

Accession Number:: 0001649094-24-000080
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-10-08 20:32:26
Reporting Period:: 2024-10-07

Accepted Time:: 2024-10-08 20:32:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1649094	Vaxcyte Inc.	PCVX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1258693	Grant Pickering	C/O Vaxcyte, Inc. 825 Industrial Road, Ste. 300 San Carlos CA 94070	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-10-07	310	$107.27	141,820	No	4	S	Indirect	By Children's Trust
Common Stock	Disposition	2024-10-07	887	$108.72	140,933	No	4	S	Indirect	By Children's Trust
Common Stock	Disposition	2024-10-07	2,113	$109.58	138,820	No	4	S	Indirect	By Children's Trust
Common Stock	Disposition	2024-10-07	239	$110.35	138,581	No	4	S	Indirect	By Children's Trust
Common Stock	Disposition	2024-10-07	356	$107.50	141,774	No	4	S	Indirect	By Children's Trust
Common Stock	Disposition	2024-10-07	807	$108.75	140,967	No	4	S	Indirect	By Children's Trust
Common Stock	Disposition	2024-10-07	1,849	$109.43	139,118	No	4	S	Indirect	By Children's Trust
Common Stock	Disposition	2024-10-07	537	$110.20	138,581	No	4	S	Indirect	By Children's Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Children's Trust
No	4	S	Indirect	By Children's Trust
No	4	S	Indirect	By Children's Trust
No	4	S	Indirect	By Children's Trust
No	4	S	Indirect	By Children's Trust
No	4	S	Indirect	By Children's Trust
No	4	S	Indirect	By Children's Trust
No	4	S	Indirect	By Children's Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	450,219	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024.
The price reported is a weighted-average price. The shares were sold at prices ranging from $107.08 to $108.07. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Shares are held directly by a trust for the benefit of the Reporting Person's son.
The price reported is a weighted-average price. The shares were sold at prices ranging from $108.11 to $109.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $109.17 to $110.16. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $110.235 to $111.12. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
The price reported is a weighted-average price. The shares were sold at prices ranging from $108.14 to $109.12. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $109.16 to $110.075. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $110.16 to $111.12. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.